Rachid Baz, MD

Dr. Rachid Baz is a board-certified hematologist and medical oncologist who came to Moffitt in 2008 from the Cleveland Clinic. Currently, Dr. Baz is Myeloma Section Head in the Department of Malignant Hematology at Moffitt Cancer Center. In addition, he is the Director of Clinical Research in the Malignant Hematology Department.

He received his medical degree from American University of Beirut. He completed his residencies in Internal Medicine and Hematology and Medical Oncology from Cleveland Clinic Foundation.

Dr. Baz has developed a special expertise in managing patients with plasma cell disorders such as multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, primary systematic amyloidosis, and Waldenstrom’s macroglobulinemia (WM). Among other awards, he was the recipient of the Junior Clinical Science Award at Moffitt, and the University of South Florida Outstanding Resident Teaching Award.

Representative Publications:

The Potential of Ixazomib, a Second-Generation Proteasome Inhibitor, in the Treatment of Multiple Myeloma
A Phase 1 Clinical Trial of Single-Agent Selinexor in Acute Myeloid Leukemia
Merkel Cell Carcinoma in the Peripheral Blood of a Patient With Concomitant Chronic Lymphocytic Leukemia and Multiple Myeloma
Lenalidomide-based response-adapted therapy for older adults without high risk myeloma
Impact of Socioeconomic Status and Distance from Treatment Center on Survival In Patients Receiving Remission Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia